Davidovic L B, Spasic D S, Lotina S I, Kostic D M, Cinara I S, Svetkovic S D, Djordic P M
Institute of Cardiovascular Diseases, Clinical Centre of Serbia, Belgrade.
Srp Arh Celok Lek. 2001 Jul-Aug;129(7-8):183-93.
The aorto-enteric fistula (AEF) is a direct communication between aorta and intestinal lumen. There are primary and secondary forms. Primary AEFs are usually due to erosion of an aortic aneurysm (AAA) into the intestine, while secondary forms are caused by reconstructive procedures on the abdominal aorta. The incidence of primary AEF ranges from 0.1 to 0.8%, and secondary from 0.4% to 2.4% [2-4]. The mortality rate after surgical treatment of secondary AEFs is from 14% to 70% [5]. Therefore, they are of great medical importance. The aim of this paper is the presentation of 9 new cases.
Over a 33-year period (1966-1999) a retrospective analysis of patients' records identified 9 patients with AEFs. All were males with average age of 66.62 (51-70) years. In Tables 1 and 2 are presented data on our cases. Of the total number of 9 patients, there were 4 primary and 5 secondary AEFs. All primary fistulas were caused by AAA rupture. Secondary AEFs developed after aortic abdominal surgery in the period between one and seven years after the operation. In 7 cases fistula involved the duodenum, in one the sigmoid and in one the transversal colon. The dominant manifestation of fistulas was gastrointestinal bleeding: melaena--8 (89%); haematemesis and melaena--2 (22%); proctorrhagia--1 (11%). In cases of primary AEFs gastrointestinal bleeding was followed by low back pain and haemorrhagic shok, while in cases of secondary AEFs by sepsis (fever, increased leucocytes count, sedimentation). In two cases the final diagnosis was established by gastrography and colonoscopy, while in two patients Duplex ultrasonographic examination suspected AEF. In all other cases the diagnosis was established intraoperatively (Figure 1). After aneurysmal resection in cases of primary AEFs, revascularization of the lower limbs was performed with extra-anatomic axillo-bifemoral bypass graft (one case) and with "in situ" graft placement (three cases) (Figure 2). The duodenal defect was closed transversally with standard two layers suture techniques in two patients without fistula excision, and in two cases after fistulas excision. In one case associated gastero-entero and entero-entero anastomosis was performed. In all cases with secondary AEFs, after removing of the previously implanted aortic graft, the aorta was closed just below the renal arteries root, and wrapped with a vascularized pedicle of omentum, to separate it from the bowel and the contained area. The duodenal defect was closed after fistulas excision using two layers transversal suture technique in two cases, and in one patient with large fistula a partial duodenectomy and Roux's procedure were necessary. In two patients in whom AEFs involved the transversal and sigmoid colon colostoma was performed. In three cases an extra-anatomic axillo-bifemoral bypass graft was performed for lower limbs revascularization, and in one patient bypass from the ascendent aorta to the femoral artery, using retroperitoneal route was carried out. In one patient the revascularization of the lower limbs was not done because of intraoperative death of the patient.
Seven of our patients died during the first 15 postoperative days. One died during the operation after massive acute myocardial infarction. In other six cases the mortality causes were: MOFS-3 cases, and secondary enteric fistula-3 cases. Two of our patients survived. One has been followed-up for 15 years, and his axillo-bifemoral bypass is patent. The other with bypass from the ascendent aorta to the femoral artery died 7 years after the operation, also with patent graft. More details are given in Table 3.
Sir Astley Cooper was the first who described primary AEFs caused by AAA rupture in 1817 [6], and Brock in 1953, first described secondary AEF developed 6 months after aortic homograft implantation [8]. In 1957, Haberer successfully treated primary AEF by suture of the duodenal defect and aneurysmorrhaphy [9]. In our country Stojanovitsh and Vujadinovitsh in 1966, first treated primary AEF [16]. Their patient died due to MOFS. However, in 1984 and 1985, Lotina successfully treated two patients with secondary AEFs [11] (Figure 3, Sheme 1). The authors also analyzed literature data on the aetiology, pathogenesis, clinical manifestations, diagnosis and treatment of AEFs. In conclusion, the authors suggest: 1. "Omega" extra-anatomic bypass from supraceliac artery trough retroperitonely to femoral arteries; 2. "In situ" replacement of the abdominal aorta using cadaveric homografts; 3. Intraoperative control of bleeding with endoluminal balloon occlusive aortic catheter.
主动脉肠瘘(AEF)是主动脉与肠腔之间的直接连通。有原发性和继发性两种形式。原发性AEF通常是由于主动脉瘤(AAA)侵蚀肠道所致,而继发性形式则由腹主动脉重建手术引起。原发性AEF的发生率为0.1%至0.8%,继发性为0.4%至2.4%[2 - 4]。继发性AEF手术治疗后的死亡率为14%至70%[5]。因此,它们具有重要的医学意义。本文旨在介绍9例新病例。
在33年期间(1966 - 1999年),对患者记录进行回顾性分析,确定了9例AEF患者。均为男性,平均年龄66.62(51 - 70)岁。表1和表2列出了我们病例的数据。9例患者中,有4例原发性AEF和5例继发性AEF。所有原发性瘘均由AAA破裂引起。继发性AEF在主动脉腹部手术后1至7年出现。7例瘘累及十二指肠,1例累及乙状结肠,1例累及横结肠。瘘的主要表现为胃肠道出血:黑便——8例(89%);呕血和黑便——2例(22%);直肠出血——1例(11%)。原发性AEF病例中,胃肠道出血后出现腰痛和出血性休克,而继发性AEF病例中则出现败血症(发热、白细胞计数增加、血沉加快)。2例通过胃造影和结肠镜检查确诊,2例经双功超声检查怀疑为AEF。所有其他病例均在术中确诊(图1)。原发性AEF病例行动脉瘤切除术后,1例采用解剖外腋 - 双股旁路移植术、3例采用“原位”移植术进行下肢血管重建(图2)。2例患者未切除瘘管,采用标准两层缝合技术横向关闭十二指肠缺损,2例切除瘘管后进行缝合。1例进行了相关的胃 - 肠和肠 - 肠吻合术。所有继发性AEF病例,在移除先前植入的主动脉移植物后,在肾动脉根部下方关闭主动脉,并用带血管蒂的大网膜包裹,使其与肠道及周围区域隔开。2例切除瘘管后采用两层横向缝合技术关闭十二指肠缺损,1例瘘口较大的患者需要行部分十二指肠切除术和Roux手术。2例AEF累及横结肠和乙状结肠的患者进行了结肠造口术。3例采用解剖外腋 - 双股旁路移植术进行下肢血管重建,1例经腹膜后途径行升主动脉至股动脉旁路移植术。1例患者因术中死亡未进行下肢血管重建。
7例患者在术后15天内死亡。1例在手术中因大量急性心肌梗死死亡。其他6例死亡原因分别为:多器官功能衰竭综合征(MOFS)——3例,继发性肠瘘——3例。2例患者存活。1例随访15年,其腋 - 双股旁路移植血管通畅。另1例升主动脉至股动脉旁路移植术患者术后7年死亡,移植血管也通畅。表3给出了更多详细信息。
阿斯特利·库珀爵士于1817年首次描述了由AAA破裂引起的原发性AEF[6],1953年布罗克首次描述了主动脉同种异体移植术后6个月出现的继发性AEF[8]。1957年,哈贝勒通过缝合十二指肠缺损和动脉瘤修补术成功治疗了原发性AEF[9]。1966年,我国的斯托亚诺维奇和武亚迪诺维奇首次治疗原发性AEF[16]。他们的患者因MOFS死亡。然而,1984年和1985年,洛蒂娜成功治疗了2例继发性AEF患者[11](图3,方案1)。作者还分析了关于AEF的病因、发病机制、临床表现、诊断和治疗的文献数据。总之,作者建议:1. 经腹膜后从腹腔动脉上方至股动脉的“Ω”形解剖外旁路;2. 用尸体同种异体移植物“原位”置换腹主动脉;3. 术中用腔内球囊闭塞主动脉导管控制出血。